These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5340774)

  • 21. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 22. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 23. The lipids of Mycobacterium tuberculosis BCG: fractionation, composition, turnover and the effects of isoniazid.
    Brennan PJ; Rooney SA; Winder FG
    Ir J Med Sci; 1970 Jun; 3(6):269-84. PubMed ID: 4988911
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of isoniazid on the triglycerides of BCG.
    Winder FG; Rooney SA
    Am Rev Respir Dis; 1968 May; 97(5):938-40. PubMed ID: 4869539
    [No Abstract]   [Full Text] [Related]  

  • 25. An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. II. Correlation of this reaction with the binding and metabolism of isoniazid.
    Youatt J; Tham SH
    Am Rev Respir Dis; 1969 Jul; 100(1):31-7. PubMed ID: 4978760
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimycobacterial and synergistic effects of 18β-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis.
    Zhou X; Zhao L; Liu X; Li X; Jia F; Zhang Y; Wang Y
    Phytother Res; 2012 Feb; 26(2):253-8. PubMed ID: 21656601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.
    Sechi LA; Zanetti S; Sanguinetti M; Molicotti P; Romano L; Leori G; Delogu G; Boccia S; La Sorda M; Fadda G
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1645-8. PubMed ID: 11353606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
    Wilkinson BL; Long H; Sim E; Fairbanks AJ
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6265-7. PubMed ID: 18926698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of isoniazid by Mycobacterium tuberculosis BCG with reference to current theories of the mode of action.
    YOUATT J
    Am Rev Tuberc; 1958 Nov; 78(5):806-9. PubMed ID: 13583450
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE MECHANISM OF ACTION OF ETHIONAMIDE.
    TSUKAMURA M; TSUKAMURA S; MIZUNO S; NAKANO E
    Am Rev Respir Dis; 1964 Jun; 89():933-5. PubMed ID: 14169423
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distribution of 35S-labelled BCG and 35S-labelled bacteria metabolites in the organism of guinea pigs].
    Meissner J
    Nucl Med (Stuttg); 1971 Apr; 10(1):85-102. PubMed ID: 4932572
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of isoniazid on nicotinamide nucleotide concentrations in tubercle bacilli. A correction and further observations.
    Winder FG; Collins P
    Am Rev Respir Dis; 1969 Jul; 100(1):101-3. PubMed ID: 4389610
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
    McLaughlin AM; Gibbons N; Fitzgibbon M; Power JT; Foley SC; Hayes JP; Rogers T; Keane J
    Am J Respir Crit Care Med; 2012 Jul; 186(1):110-1. PubMed ID: 22753693
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene replacement in Mycobacterium bovis BCG.
    Norman E
    Methods Mol Biol; 1998; 101():225-33. PubMed ID: 9921482
    [No Abstract]   [Full Text] [Related]  

  • 38. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the endogenous metabolism of mycobacteria. 3. On the influence of isonicotinic acid hydrazide on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Naturforsch B; 1968 Jul; 23(7):982-9. PubMed ID: 4387665
    [No Abstract]   [Full Text] [Related]  

  • 40. [The influence of phosphate content in culture media on nicotinic acid metabolism of Mycobacterium bovis (strain BCG)].
    Reutgen H; Gross D; Zureck A; Feige A; Iwainsky H; Schütte HR
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(1):53-63. PubMed ID: 4922248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.